Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Abbvie Reports First Provincial Reimbursements for VENCLEXTA in Combination with Azacitidine for Acute Myeloid Leukemia Patients
AbbVie (NYSE: ABBV) has reported an agreement with the pan-Canadian Pharmaceutical Alliance for VENCLEXTA in combination with azacytidine for treatment of patients that are diagnosed with acute myeloid leukemia...